Congenital Heart Disease

Welcome to the Congenital Heart Disease (CHD) page. Mayo Clinic has cared for child and adult patients living with CHD for more than 60 years. With extensive expertise in treating people with rare and common congenital heart defects, our medical specialists provide exactly the care you need.

Follow the CHD page and stay up-to-date as we post stories, clinical trials, resources and other useful information to help you and your loved ones along the CHD journey. Post a comment and share your thoughts.

Apr 25, 2018

The Role of Anticoagulation in Fontan Patients

By Alexander C. Egbe, M.B.B.S., @alexegbe

Anticoagulation in Fontan Patients

Mayo Clinic congenital cardiologist, Alexander Egbe, M.B.B.S., discusses the role of anticoagulation in Fontan patients.

Thromboembolism, or blood clots, can affect all systems in the body causing stroke, pulmonary embolism, and heart attacks. In Fontan patients, blood clots are typically found in the heart, Fontan connection, or in the calf, also known as deep vein thrombosis or DVT.

Fontan patients are at a higher risk for blood clots due to sluggish blood flow, arrhythmias, hereditary clotting disorders, or cirrhosis. Decisions on medical therapy with warfarin or aspirin should be determined on a case-by-case basis.

Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Congenital Heart Disease page.

We'll include this text in the user's invitation.